EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 0.3471
March 31, 2026 0.125
December 31, 2025 0.1571
September 30, 2025 0.4461
June 30, 2025 -2.786
March 31, 2025 -2.290
December 31, 2024 -2.202
September 30, 2024 -2.052
June 30, 2024 1.287
March 31, 2024 1.393
December 31, 2023 0.7757
September 30, 2023 0.0778
June 30, 2023 -0.1656
March 31, 2023 -0.2818
December 31, 2022 0.2904
September 30, 2022 0.3956
June 30, 2022 0.7991
March 31, 2022 0.8389
December 31, 2021 0.9175
September 30, 2021 1.357
June 30, 2021 3.908
March 31, 2021 3.317
December 31, 2020 3.282
September 30, 2020 2.840
June 30, 2020 -0.2447
Date Value
March 31, 2020 -0.008
December 31, 2019 -0.2659
September 30, 2019 0.0473
June 30, 2019 0.1779
March 31, 2019 0.1749
December 31, 2018 -0.0203
September 30, 2018 -0.1065
June 30, 2018 -0.2809
March 31, 2018 -0.8324
December 31, 2017 -1.09
September 30, 2017 -1.31
June 30, 2017 -1.71
March 31, 2017 -1.43
December 31, 2016 -1.01
September 30, 2016 -0.97
June 30, 2016 -0.3048
March 31, 2016 -0.0946
December 31, 2015 0.0354
September 30, 2015 0.2454
June 30, 2015 0.0902
March 31, 2015 -0.05
December 31, 2014 -0.42
September 30, 2014 -0.92
June 30, 2014 -1.28
March 31, 2014 -1.56

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Viatris, Inc. -0.3572
Johnson & Johnson 8.628
Liquidia Corp. 1.364
Organon & Co. 0.7806
ANI Pharmaceuticals, Inc. 4.632